Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 7, 2015, Pages 1162-1169

  Guessous, Idris ^a,c,d   McClellan, William ^d   Kleinbaum, David ^d   Vaccarino, Viola ^d   Hugues, Henry ^b   Boulat, Olivier ^b   Marques Vidal, Pedro ^a,b   Paccaud, Fred ^a   Theler, Jean Marc ^c   Gaspoz, Jean Michel ^c   Burnier, Michel ^b   Waeber, Gérard ^b   Vollenweider, Peter ^b   Bochud, Murielle ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CREATININE; GLUCOSE DEHYDROGENASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER;

ADULT; ALBUMINURIA; ALTITUDE; ARTICLE; CHRONIC KIDNEY DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOASSAY; INCIDENCE; KIDNEY FUNCTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; QUESTIONNAIRE; SENSITIVITY ANALYSIS; SUN EXPOSURE; TANDEM MASS SPECTROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGED; ANALOGS AND DERIVATIVES; BLOOD; HEALTH SURVEY; KIDNEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROGNOSIS; PROTECTION; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; SWITZERLAND; TIME FACTOR;

ADULT; AGED; ALBUMINURIA; BIOMARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PREVALENCE; PROGNOSIS; PROTECTIVE FACTORS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; SWITZERLAND; TANDEM MASS SPECTROMETRY; TIME FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84936867019     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04960514     Document Type: Article

References (40)

1. Al-Badr W, Martin KJ: Vitamin D and kidney disease. Clin J Am Soc Nephrol 3: 1555-1560, 2008
2. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease. Kidney Int 71: 31-38, 2007
3. Agarwal R: Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Clin J Am Soc Nephrol 4: 1523-1528, 2009
4. de Boer IH, Ioannou GN, Kestenbaum B, Brunzell JD, Weiss NS: 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 50: 69-77, 2007
5. Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Lu ZX, Ebeling PR, Chadban SJ, Atkins RC, Kerr PG, Shaw JE, Polkinghorne KR: 25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol 13: 55, 2012
6. Isakova T, Gutiérrez OM, Patel NM, Andress DL, Wolf M, Levin A: Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr 21: 295-302, 2011
7. Patel S, Barron JL, Mirzazedeh M, Gallagher H, Hyer S, Cantor T, Fraser WD: Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages. J Bone Miner Metab 29: 71-79, 2011
8. Chonchol M, Scragg R: 25-HydroxyvitaminD, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 71: 134-139, 2007
9. de Boer IH, Katz R, Chonchol M, Ix JH, Sarnak MJ, Shlipak MG, Siscovick DS, Kestenbaum B: Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate. Clin J Am Soc Nephrol 6: 2141-2149, 2011
10. Oh YJ, Kim M, Lee H, Lee JP, Kim H, Kim S, Oh KH, Joo KW, Lim CS, Kim S, Kim YS, Kim DK: A threshold value of estimated glomerular filtration rate that predicts changes in serum 25-hydroxyvitamin D levels: 4th Korean National Health and Nutritional Examination Survey 2008. Nephrol Dial Transplant 27: 2396-2403, 2012
11. Bosworth CR, Levin G, Robinson-Cohen C, Hoofnagle AN, Ruzinski J, Young B, Schwartz SM, Himmelfarb J, Kestenbaum B, de Boer IH: The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Kidney Int 82: 693-700, 2012
12. Bosworth C, de Boer IH: Impaired vitaminDmetabolism in CKD. Semin Nephrol 33: 158-168, 2013
13. Quarles LD: Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease. Exp Cell Res 318: 1040-1048, 2012
14. O’Seaghdha CM, Hwang SJ, Holden R, Booth SL, Fox CS: Phylloquinone and vitamin D status: Associations with incident chronic kidney disease in the FraminghamOffspring cohort. AmJ Nephrol 36: 68-77, 2012
15. Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Lu ZX, Sikaris KA, Ebeling PR, Chadban SJ, Atkins RC, Kerr PG, Shaw JE, Polkinghorne KR: Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD. Am J Kidney Dis 62: 58-66, 2013
16. van Schoor NM, Lips P: Worldwide vitamin D status. Best Pract Res Clin Endocrinol Metab 25: 671-680, 2011
17. Firmann M, Mayor V, Vidal PM, Bochud M, Pécoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, Danoff TM, Stirnadel HA, Waterworth D, Mooser V, Waeber G, Vollenweider P: The Co- Laus study: A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 8: 6, 2008
18. El Assaad MA, Topouchian JA, Darne´ BM, Asmar RG: Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit 7: 237-241, 2002
19. Li Y, Willer C, Sanna S, Abecasis G: Genotype imputation. Annu Rev Genomics Hum Genet 10: 387-406, 2009
20. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
21. Bruce SJ, Rochat B, Béguin A, Pesse B, Guessous I, Boulat O, Henry H: Analysis and quantification of vitamin Dmetabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry—a method comparison and validation. Rapid Commun Mass Spectrom 27: 200-206, 2013
22. Holick MF: Vitamin D deficiency. N Engl J Med 357: 266-281, 2007
23. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA: The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96: 53-58, 2011
24. de Boer IH, Levin G, Robinson-Cohen C, Biggs ML, Hoofnagle AN, Siscovick DS, Kestenbaum B: Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: A cohort study. Ann Intern Med 156: 627-634, 2012
25. Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ: Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 168: 2212-2218, 2008
26. Turin TC, James M, Ravani P, Tonelli M, Manns BJ, Quinn R, Jun M, Klarenbach S, Hemmelgarn BR: Proteinuria and rate of change in kidney function in a community-based population. J Am Soc Nephrol 24: 1661-1667, 2013
27. Zoppini G, Targher G, Chonchol M, Ortalda V, Negri C, Stoico V, Bonora E: Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. Clin J Am Soc Nephrol 7: 401-408, 2012
28. Glymour MM, Weuve J, Berkman LF, Kawachi I, Robins JM: When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol 162: 267-278, 2005
29. Tu YK, Gilthorpe MS: Revisiting the relation between change and initial value: A review and evaluation. Stat Med 26: 443-457, 2007
30. Tu YK, Gunnell D, Gilthorpe MS: Simpson’s Paradox, Lord’s Paradox, and Suppression Effects are the same phenomenon— the reversal paradox. Emerg Themes Epidemiol 5: 2, 2008
31. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C: Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 75: 88-95, 2009
32. Llach F, Yudd M: Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure. Am J Kidney Dis 32[Suppl 2]: S3-S12, 1998
33. Sato KA, Gray RW, Lemann J Jr: Urinary excretion of 25-hydroxyvitamin D in health and the nephrotic syndrome. J Lab Clin Med 99: 325-330, 1982
34. Li YC: Renoprotective effects of vitaminDanalogs. Kidney Int 78: 134-139, 2010
35. Krajisnik T, Björklund P, Marsell R, Ljunggren O, Akerström G, Jonsson KB, Westin G, Larsson TE: Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195: 125-131, 2007
36. Initiative KDOQ; National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42[Suppl 3]: S1-S201, 2003
37. Kim CS, Kim SW: VitaminDand chronic kidney disease. Korean J Intern Med 29: 416-427, 2014
38. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S: Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis 58: 374-382, 2011
39. Tu YK, West R, Ellison GT, Gilthorpe MS: Why evidence for the fetal origins of adult disease might be a statistical artifact: The “reversal paradox” for the relation between birth weight and blood pressure in later life. Am J Epidemiol 161: 27-32, 2005
40. Harris SS: Vitamin D and African Americans. J Nutr 136: 1126-1129, 2006